| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |